134 related articles for article (PubMed ID: 2492364)
1. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
Mabuchi H; Itoh H; Takeda M; Kajinami K; Wakasugi T; Koizumi J; Takeda R; Asagami C
Metabolism; 1989 Feb; 38(2):115-9. PubMed ID: 2492364
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
3. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
4. Familial apolipoprotein E deficiency.
Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.
Todo Y; Kobayashi J; Higashikata T; Kawashiri M; Nohara A; Inazu A; Koizumi J; Mabuchi H
Clin Chim Acta; 2004 Oct; 348(1-2):35-40. PubMed ID: 15369733
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
[TBL] [Abstract][Full Text] [Related]
7. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
Marcoux C; Tremblay M; Nakajima K; Davignon J; Cohn JS
J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287
[TBL] [Abstract][Full Text] [Related]
8. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.
Feussner G; Wingen AM; Ziegler R
Metabolism; 1990 Nov; 39(11):1196-9. PubMed ID: 2233282
[TBL] [Abstract][Full Text] [Related]
9. A phenocopy of type III dysbetalipoproteinemia occurring in a candidate family for a putative apo E receptor defect.
Davignon J; Dallongeville J; Roederer G; Roy M; Fruchart JC; Kessling AM; Bouthillier D; Lussier-Cacan S
Ann Med; 1991 Apr; 23(2):161-7. PubMed ID: 1648930
[TBL] [Abstract][Full Text] [Related]
10. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
Lin HP; Kao JT
Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
[TBL] [Abstract][Full Text] [Related]
12. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.
Fazio S; Lee YL; Ji ZS; Rall SC
J Clin Invest; 1993 Sep; 92(3):1497-503. PubMed ID: 8376602
[TBL] [Abstract][Full Text] [Related]
13. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
Ghiselli G; Schaefer EJ; Gascon P; Breser HB
Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.
Ishigami M; Yamashita S; Sakai N; Hirano K; Hiraoka H; Nakamura T; Matsuzawa Y
Atherosclerosis; 2003 Jun; 168(2):359-66. PubMed ID: 12801620
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
[TBL] [Abstract][Full Text] [Related]
16. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.
Wang T; Nakajima K; Leary ET; Warnick GR; Cohn JS; Hopkins PN; Wu LL; Cilla DD; Zhong J; Havel RJ
Clin Chem; 1999 Nov; 45(11):1981-7. PubMed ID: 10545069
[TBL] [Abstract][Full Text] [Related]
17. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
[TBL] [Abstract][Full Text] [Related]
18. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
Nakajima K; Daimon M; Kamiyama K; Takanashi K; Suzuki Y; Watanabe M; Kubono K; Saniabadi AR; Takashima S; Sakurabayashi I
Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.
Kameda K; Matsuzawa Y; Kubo M; Ishikawa K; Maejima I; Yamamura T; Yamamoto A; Tarui S
Atherosclerosis; 1984; 51(2-3):241-9. PubMed ID: 6743382
[TBL] [Abstract][Full Text] [Related]
20. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
